Please register (it's free!) or login to view the remaining preview.

If you are logged in, your referral link [?] is automatically included below.

EMBED CODE (Copy and Paste)

BENEFITS OF DOCUMENT

The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025
Currently approved therapies will continue to have a meaningful impact on the multiple myeloma treatment algorithm and market sales
Major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025

DOCUMENT DESCRIPTION

The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025, with major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025. Growth will be fueled by the continued uptake and label expansions of current therapies and the expected market entry of four novel, premium-priced therapies. Immunomodulatory agents are, and will remain, the dominant drug class throughout the forecast period and will capture more than 50% of major-market sales in 2025.

Currently approved therapies will continue to have a meaningful impact on the multiple myeloma treatment algorithm and market sales. Lenalidomide is set to retain its position as the sales-leading agent in multiple myeloma, with sales expected to reach more than $11.7 billion across the seven major markets in 2025. Continued penetration of the R/R setting will provide significant revenue, as will its label expansion in the first-line setting, in addition to use in combination with recently approved and emerging agents, such as carfilzomib, ixazomib, elotuzumab, daratumumab, and pembrolizumab.
Introduction
Key Findings
Market Share of Cancer Drug Classes in 2015 and 2025
Market SWOT Analysis
Etiology and Pathophysiology
Key Findings
Expert Insight
Pathophysiology
Anatomy
Subtypes
Staging and Classification
Key Pathways and Drug Targets
Market Outlook
Key Findings
Expert Insight
Market Overview
Market Drivers and Constraints
What Factors Are Driving the Market?
What Factors Are Constraining the Market?

Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Market Overview: Multiple Myeloma PDF document

Market Overview: Multiple Myeloma

Sold by pharmzolgas (this author has 4 documents)

$299.00

ALL FEES INCLUDED

Add to Cart

This business document is categorized under the function(s):

Pharma Industry Strategy, Marketing, & Sales

It applies to Healthcare & Life Sciences

File Type: PDF (pdf)

File Size: 1.9 MB

Number of Pages: 27

Related Topic(s): Healthcare Cancer

Purchase includes lifetime product updates. After your purchase, you will receive an email to download this document.

Initial upload date (first version): Mar 8, 2017
Most recent version published: Mar 10, 2017

Ask the Author a Question

Must be logged in Click here to log in

CUSTOMER TESTIMONIALS

"As a niche strategic consulting firm, Flevy and FlevyPro frameworks and documents are an on-going reference to help us structure our findings and recommendations to our clients as well as improve their clarity, strength, and visual power. For us, it is an invaluable resource to increase our impact and value."

– David Coloma, Consulting Area Manager at Cynertia Consulting

"My FlevyPro subscription provides me with the most popular frameworks and decks in demand in today’s market. They not only augment my existing consulting and coaching offerings and delivery, but also keep me abreast of the latest trends, inspire new products and service offerings for my practice, and educate me in a fraction of the time and money of other solutions. I strongly recommend FlevyPro to any consultant serious about success."

– Bill Branson, Founder at Strategic Business Architects

"FlevyPro has been a brilliant resource for me, as an independent growth consultant, to access a vast knowledge bank of presentations to support my work with clients. In terms of RoI, the value I received from the very first presentation I downloaded paid for my subscription many times over! The quality of the decks available allows me to punch way above my weight – it's like having the resources of a Big 4 consultancy at your fingertips at a microscopic fraction of the overhead."

– Roderick Cameron, Founding Partner at SGFE Ltd

"As an Independent Management Consultant, I find Flevy to add great value as a source of best practices, templates and information on new trends. Flevy has matured and the quality and quantity of the library is excellent. Lastly the price charged is reasonable, creating a win-win value for the customer, Flevy and the various authors. This is truly a service that benefits the consulting industry and associated clients. Thanks for providing this service. "

– Jim Schoen, Principal at FRC Group

"Flevy is our 'go to' resource for management material, at an affordable cost. The Flevy library is comprehensive and the content deep, and typically provides a great foundation for us to further develop and tailor our own service offer."

– Chris McCann, Founder at Resilient.World

"Flevy is now a part of my business routine. I visit Flevy at least 3 times each month.

Flevy has become my preferred learning source, because what it provides is practical, current, and useful in this era where the business world is being rewritten.

In today's environment where there are so many challenges and there is the need to make the right decisions in a short time, with so much scattered information, we are fortunate to have Flevy. Flevy investigates, selects, and puts at our disposal the best of the best to help us be successful in our work."

– Omar Hernán Montes Parra, CEO at Quantum SFE

"FlevyPro provides business frameworks from many of the global giants in management consulting that allow you to provide best in class solutions for your clients."

– David Harris, Managing Director at Futures Strategy

"The wide selection of frameworks is very useful to me as an independent consultant. In fact, it rivals what I had at my disposal at Big 4 Consulting firms in terms of efficacy and organization."

– Julia T., Consulting Firm Owner (Former Manager at Deloitte and Capgemini)

"As a consulting firm, we had been creating subject matter training materials for our people and found the excellent materials on Flevy, which saved us 100's of hours of re-creating what already exists on the Flevy materials we purchased."

– Michael Evans, Managing Director at Newport LLC

"If you are looking for great resources to save time with your business presentations, Flevy is truly a value-added resource. Flevy has done all the work for you and we will continue to utilize Flevy as a source to extract up-to-date information and data for our virtual and onsite presentations!"

– Debbi Saffo, President at The NiKhar Group

SELECT CUSTOMERS

Since 2012, we have provided best practices to over 5,000 businesses and organizations of all sizes across the world—in over 130 countries. Below is just a very small sample of our customer base.

Did you know?

The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.

CUSTOMERS ALSO BOUGHT THESE DOCUMENTS

Healthcare Business Capability Model 1-page PDF document $30.00 Author: R Bradley Consulting Healthcare	Pharma launch plan 2020 57-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Lean Healthcare 180-slide PowerPoint deck $79.00 Author: Operational Excellence Consulting Healthcare	Healthcare Go-to-Market Strategy 65-slide PowerPoint deck $49.00 Author: PPT Lab Healthcare
Pharma Field Force Effectiveness Guide 211-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Pharma Marketing Plan 2.0 277-slide PowerPoint deck $199.00 Author: BigPharma2000 Healthcare	Pharma Brand Plan 39-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Key Account Management (KAM) in Healthcare and Pharma 23-slide PowerPoint deck $20.00 This is a FlevyPro [?] document. Subscribe and save with FlevyPro! Healthcare
Pharma Disease Insight: Colorectal Cancer 28-slide PowerPoint deck $99.00 Author: BigPharma2000 Cancer	Pharma Brand Building 183-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Big Pharma: Brand Plan (German Style) 39-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	ISO 13485:2016 (Medical Devices - QMS) Awareness 72-slide PowerPoint deck $69.00 Author: Operational Excellence Consulting Quality Management & Assurance Healthcare